Only very limited patients in the triple combo currently, never the less very encouraging data,
efficacy from 10 patients. Early efficacy signals from 10 of 14 patients show ORR of 70% and Disease Control Rate (DCR) of 90% (according to RECIST 1.1), of course noting the very small patient subset evaluated (n=10). It is encouraging at this early stage only 1 of 10 patients have progressive disease.
- Forums
- ASX - By Stock
- Overnight Market report
Only very limited patients in the triple combo currently, never...
-
- There are more pages in this discussion • 1,696 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
37.5¢ |
Change
0.005(1.35%) |
Mkt cap ! $548.3M |
Open | High | Low | Value | Volume |
37.0¢ | 38.3¢ | 37.0¢ | $577.8K | 1.537M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
25 | 209884 | 37.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.5¢ | 116701 | 37 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
29 | 220705 | 0.370 |
13 | 163114 | 0.365 |
13 | 192660 | 0.360 |
9 | 88376 | 0.355 |
10 | 197670 | 0.350 |
Price($) | Vol. | No. |
---|---|---|
0.375 | 94073 | 33 |
0.380 | 168734 | 13 |
0.385 | 265727 | 17 |
0.390 | 242707 | 12 |
0.395 | 125873 | 10 |
Last trade - 12.53pm 23/08/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online